Pharmafile Logo
Pharmafocus logo
Advanced Search

EMEA

Showing 10 posts of 10 posts found.

Jane Griffiths, company group chairman for Janssen EMEA and chairwoman of the EF

Janssen: why transparency is essential to the health of our industry

August 29, 2014
Medical Communications, Research and Development, Sales and Marketing EFPIA, EMEA, Goldacre, Janssen, alltrials, transparency

The pharmaceutical industry is moving forward, working together to ensure patients have access to new and innovative medicines.However, more must …

News
Eisai logo

Eisai expands UK base

March 21, 2012
Sales and Marketing EMEA, Eisai, Hatfield, expansion

Eisai is expanding its UK headquarters to support the company’s growing European, Middle Eastern and African business. The expansion will …

News
Europe map

EMA readies paediatric trials network

May 14, 2010
Research and Development EMA, EMEA, paediatric, paediatric trials

The European Medicines Agency is about to press the start button on its long-planned network for clinical studies in children. …

News

In brief: European Medicines Agency news

January 26, 2010
Research and Development, Sales and Marketing Arepanrix, Arzerra, EMEA, GSK, Tysabri

GlaxoSmithKline’s influenza vaccine Arepanrix has been granted conditional marketing authorisation in Europe under an emergency fast-track procedure.It is the fourth …

News
The European Medicines Agency concedes greater engagement is needed

Patient involvement must improve, says European regulator

December 31, 2009
Sales and Marketing EMEA, patients

The European Medicines Agency (EMEA) has admitted that the level of patient involvement in its activities is unsatisfactory.As a result …

News

EMA: Aligning regulation with the lifecycle of medicines

November 30, 2009
Research and Development EMA, EMEA, Thomas Lönngren, regulatory affairs

The European Agency for the Evaluation of Medicinal Products was set up in 1995 in London’s Docklands, an isolated eastern …

Feature

European regulator restructures

October 7, 2009
Sales and Marketing EMEA, EU

News

Merck Serono asks EMEA to re-think Erbitux rejection

July 30, 2009
Research and Development, Sales and Marketing Cancer, EMEA, Erbitux, Europe, Merck Serono

Merck Serono is to appeal against the European rejection of Erbitux as a lung cancer treatment.Erbitux has been rejected as …

News

Onglyza and Cimzia recommended by CHMP

July 2, 2009
Research and Development, Sales and Marketing AZ, BMS, EMEA, Europe, Ongylza

Bristol-Myers Squibb andAstraZeneca's type II diabetes treatment Onglyza is among the brands to have received positive opinions from the Committee …

News

Lonngren lashes out at late warning

November 1, 2004
EMA, EMEA, Lonngren, Vioxx

 Thomas Lonngren, the head of Europe’s medicines regulator the EMEA has spoken out about Merck’s withdrawal of Vioxx, saying the …

News

Latest content

Merck shares data from phase 3 trial of Keytruda for gastric cancers

May 2, 2024

Verona Pharma to share phase 3 COPD trial data at ATS 2024

May 2, 2024

Beckman Coulter Life Sciences and Watchmaker Genomics enter collaboration

May 1, 2024

Veru announces first patients enrolled in phase 2b trial for weight loss treatment

May 1, 2024

Bayer and Evotec to collaborate on precision cardiology

April 30, 2024